Form 4: Agilysys Inc. Director's Trust Sells Shares Under 10b5-1 Plan

The Kaufman 2012 Descendants Trust, an affiliate of an Agilysys Inc. director, sold 22,500 shares of common stock over three days under a pre-arranged 10b5-1 trading plan.

Summary

• The Kaufman 2012 Descendants Trust, with David N. Smith as trustee, sold a total of 22,500 shares of Agilysys Inc. common stock.
• These sales occurred over three trading days: 7,500 shares on January 2, 2025, at an average price of $130.55, 7,500 shares on January 3, 2025, at an average price of $132.66, and 7,500 shares on January 6, 2025, at an average price of $130.34.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan established on September 10, 2024.
• Following these transactions, the Trust's holdings decreased to 315,576 shares.
• Michael Kaufman, a director of Agilysys Inc., is a beneficiary of the Trust but disclaims beneficial ownership of the shares held by the Trust.
• Michael Kaufman also directly owns 9,580 shares and may be deemed to indirectly own 1,192,730 shares through MAK Capital Fund LP, although he disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales under a pre-arranged plan, which is neither positive nor negative. The sales are not unexpected and do not indicate any significant change in the company's outlook.

Risks

• The sale of shares by a director's affiliate could be perceived negatively by the market, potentially impacting the stock price.
• The large number of shares sold could indicate a lack of confidence in the company's future prospects by the Trust, although this is not explicitly stated.

Management Comments

• Michael Kaufman disclaims beneficial ownership of the shares held by the Trust, except to the extent of his pecuniary interest.
• Michael Kaufman disclaims beneficial ownership of shares held by MAK Capital Fund LP, except to the extent of his pecuniary interest.

Industry Context

This filing is a routine disclosure of stock sales by an insider, which is common in the corporate world. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among corporate insiders to manage their stock sales while avoiding accusations of insider trading, similar to practices at companies like Microsoft or Apple.
• The volume of shares sold is not unusual for a trust associated with a director, and is similar to other insider sales seen in the technology sector, such as those at Oracle or Salesforce.
• The price range of the sales is within the typical trading range for Agilysys stock, and is not indicative of any unusual market activity, similar to the trading patterns of comparable companies like NCR or PAR Technology.

Stakeholder Impact

• The sale of shares by a director's affiliate could cause a slight negative reaction from shareholders, although the use of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

Agilysys Inc., Form 4, 10b5-1 plan, stock sale, insider trading, Kaufman Descendants Trust, David N. Smith, Michael Kaufman